Amarin vows to challenge Vascepa patent ruling

Amarin has announced it will seek an en banc rehearing of a decision at the US Court of Appeals for the Federal Circuit that failed to revive its patents on heart medicine Vascepa (icosapent ethyl).

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

FDA approves Dr Reddy’s Vascepa generic

13 August 2020 Indian drugmaker Dr Reddy’s has won approval to launch just the second generic version of heart drug Vascepa, in another blow for Amarin.

Americas

Ruling opens door for Noven’s oestrogen patch generics

10 September 2020 In a victory for pharmaceutical company Amneal, a Delaware court has invalidated claims of three patents covering Noven Pharmaceuticals’ Minivelle oestrogen product.

Big Pharma

Amarin petitions Supreme Court to revive Vascepa patents

18 February 2021 Irish pharmaceutical company Amarin has petitioned the Supreme Court to revive its patents on its heart medication Vascepa.

More on this story

Americas

FDA approves Dr Reddy’s Vascepa generic

13 August 2020 Indian drugmaker Dr Reddy’s has won approval to launch just the second generic version of heart drug Vascepa, in another blow for Amarin.

Americas

Ruling opens door for Noven’s oestrogen patch generics

10 September 2020 In a victory for pharmaceutical company Amneal, a Delaware court has invalidated claims of three patents covering Noven Pharmaceuticals’ Minivelle oestrogen product.

Big Pharma

Amarin petitions Supreme Court to revive Vascepa patents

18 February 2021 Irish pharmaceutical company Amarin has petitioned the Supreme Court to revive its patents on its heart medication Vascepa.

More on this story

Americas

FDA approves Dr Reddy’s Vascepa generic

13 August 2020 Indian drugmaker Dr Reddy’s has won approval to launch just the second generic version of heart drug Vascepa, in another blow for Amarin.

Americas

Ruling opens door for Noven’s oestrogen patch generics

10 September 2020 In a victory for pharmaceutical company Amneal, a Delaware court has invalidated claims of three patents covering Noven Pharmaceuticals’ Minivelle oestrogen product.

Big Pharma

Amarin petitions Supreme Court to revive Vascepa patents

18 February 2021 Irish pharmaceutical company Amarin has petitioned the Supreme Court to revive its patents on its heart medication Vascepa.